Schoenberg B S, Kokmen E, Okazaki H
Department of Neurology, Mayo Clinic, Rochester, MN 55905.
Ann Neurol. 1987 Dec;22(6):724-9. doi: 10.1002/ana.410220608.
In this study, for the first time to our knowledge all new cases of Alzheimer's disease and other dementing illnesses have been documented in a well-defined United States community. A total of 178 patients in an average annual at-risk population of 18,991 persons over age 29 developed dementia during 1960 through 1964 in Rochester, Minnesota, yielding an average annual incidence rate of 187.5 new cases/100,000/year. The corresponding rate for clinically and/or pathologically diagnosed Alzheimer's disease (the most common cause of dementia in this community) was 123.3 new cases/100,000/year, based on 117 cases. The incidence rates for both dementia in general and Alzheimer's disease in particular rise dramatically with age. All patients were followed to death or to 1982, and the median survival was 63 months. These data include only those in the community who came to medical attention, but they yield higher rates than studies in Scandinavia, indicating a relatively high level of case ascertainment.
据我们所知,在本研究中,首次对美国一个界定明确的社区内所有新增的阿尔茨海默病及其他痴呆性疾病病例进行了记录。1960年至1964年期间,在明尼苏达州罗切斯特市,平均每年有18,991名29岁以上的高危人群,其中共有178人患上痴呆症,年平均发病率为每10万人中有187.5例新发病例。临床和/或病理诊断为阿尔茨海默病(该社区最常见的痴呆病因)的相应发病率为每10万人中有123.3例新发病例,基于117例病例。总体痴呆症以及特别是阿尔茨海默病的发病率都随着年龄的增长而急剧上升。所有患者均随访至死亡或1982年,中位生存期为63个月。这些数据仅包括社区中就医的患者,但它们得出的发病率高于斯堪的纳维亚地区的研究结果,表明病例确诊水平相对较高。